Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$15,891,410
+$554,512 QoQ
Shares Held
62,572
-0.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#858
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLAND CAPITAL MANAGEMENT, LLC holds $74,462,523 across 8 Drug Manufacturers - General names. JNJ ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
233,452 | $29,998,582 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
62,572 | $15,891,410 | |
| 3 | LLY |
ELI LILLY & Co
|
10,931 | $13,110,970 | |
| 4 | ABBV |
AbbVie Inc.
|
43,576 | $10,965,464 | |
| 5 | NVS |
Novartis AG
|
13,845 | $2,169,788 | |
| 6 | GSK |
GSK plc
|
16,642 | $872,373 | |
| 7 | PFE |
Pfizer Inc
|
31,277 | $753,150 | |
| 8 | NVO |
Novo Nordisk A S
|
14,618 | $700,786 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,891,410 | 62,572 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $15,336,898 | 62,743 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $12,956,311 | 62,606 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $11,151,344 | 60,141 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $9,234,654 | 60,456 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $10,037,466 | 60,525 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $11,859,707 | 82,006 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $13,610,122 | 83,982 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $12,647,517 | 86,532 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $14,389,911 | 90,966 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $14,396,725 | 91,851 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $14,219,975 | 91,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,236,518 | 98,094 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $15,643,995 | 100,929 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $17,863,731 | 101,125 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $16,456,232 | 100,736 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $18,306,783 | 103,131 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $18,430,679 | 103,993 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $17,915,990 | 104,729 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $16,926,169 | 104,806 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $17,513,674 | 106,311 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $17,820,963 | 108,433 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $18,022,685 | 114,517 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $20,072,746 | 134,825 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $18,518,720 | 131,684 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $14,398,991 | 109,807 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||